Study of Re-irradiation at Relapse Versus RT and Multiple Elective rt Courses

NCT03620032 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Intrinsic Pontine Glioma

Interventions

DRUG: Nimotuzumab
DRUG: Vinorelbine
OTHER: Radiotherapy

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]